Influenza has begun to leave measurable traces in Romania, but the data available for early November 2026 do not support describing the situation as an epidemic. For people over 65, pregnant women, those with chronic illnesses and their families, the useful question is not whether to wait for a peak: protection after vaccination takes around two weeks to develop.
What we know now: during the week of 2–8 November, 273 clinical flu cases and five laboratory-confirmed cases were reported, according to National Institute of Public Health (INSP) data reported by AGERPRES. Since the start of the season, 34 cases and two deaths associated with influenza A/H1 had been confirmed in older people. These figures indicate early circulation worth monitoring closely, not a seasonal peak or a reason for panic.
For more information on ECDC, see Flu 2026–2027 in Romania: INSP cases, symptoms, vaccination and the risk of complications, which provides additional details on this subject.
Protecting vulnerable people from flu: three different clocks
Every autumn, the decision is easily put off from one week to the next: “we’ll see”, “there still aren’t many cases”, “perhaps we can find the vaccine later”. The problem is that three different timelines overlap.
- The virus can begin to circulate before activity becomes intense nationally.
- The body does not produce protection immediately after vaccination. Health Ministry guidance indicates that it takes around two weeks for a protective response to develop.
- Access may depend on an appointment with a doctor, obtaining a prescription and local availability, which is not necessarily the same as stock announced nationally.
This is the crucial window: not a rigid deadline, nor evidence that vaccination is no longer helpful afterwards. Vaccination can remain useful during the season, but delaying it shortens the period in which protection can develop before circulation rises more markedly.
WHO Europe says the flu season usually begins between mid-November and mid-December, with a peak often occurring in January or February. The timetable varies from year to year and cannot predict an exact date for Romania. It does, however, explain why the recommendation to arrange protection early is not merely ceremonial.
68,467 respiratory infections do not mean 68,467 flu cases
The most common confusion starts with the total reported through surveillance. For 2–8 November, INSP reported 68,467 acute respiratory infections — a broad category that includes acute upper respiratory tract infections, pneumonia and clinical flu. The total was 0.27% higher than in the previous week, but 9.8% below the average for the same period in the 2018–2025 seasons, excluding the pandemic years.
Of that total, 273 were clinical flu cases, compared with 213 in the previous week. “Clinical flu” describes a case meeting surveillance criteria on the basis of its clinical presentation; it is not equivalent to confirmation by testing. There were five laboratory confirmations in the same week: two A/H1 cases, two unsubtyped influenza A viruses and one influenza B virus.
| Indicator | What it measures | What it cannot establish on its own |
|---|---|---|
| Acute respiratory infections | The overall volume of reported respiratory illness | How many cases are flu |
| Clinical flu | Cases consistent with the clinical surveillance definition | Virus confirmation for every case |
| Laboratory confirmations | The virus identified in tested samples | The actual number of all infections in the population |
Therefore, the five confirmations are not “all the flu in Romania”, and the 273 clinical cases are not all tested cases. Read together, the figures show early circulation, with overall intensity still modest compared with the historical average.
Two deaths warrant attention, but do not alone define the season’s severity
Since the start of the 2026–2027 season, two deaths confirmed with influenza A/H1 virus have been reported: one in the 65–79 age group and one in people aged 80 or over. Every death matters, particularly when it shows the exposure of people at risk. Still, two cases alone cannot establish how severe the entire season will be, nor do they allow an individual reader’s risk to be calculated.
They do, however, reinforce the rationale for targeted measures. WHO Europe lists older adults, pregnant women, people with chronic conditions, young children and healthcare workers among the groups for whom vaccination is particularly important. The vaccine reduces risk, especially the risk of severe illness, but does not guarantee avoidance of every infection and does not protect against all respiratory viruses.
In Romania, eligibility for reimbursement should be checked with a family doctor or pharmacist. The National Health Insurance House (CNAS) protocol includes, among the groups eligible for full reimbursement, children from 6 months to under 19 years old, pregnant women, people with certain chronic illnesses, people over 65 and medical and healthcare staff. People aged 45 to under 65 without chronic illnesses are eligible for 50% reimbursement, under the terms of the current protocol.
Europe shows an upward signal, not a verdict for Romania
The European picture is consistent with a season at an early stage, but it should not be treated as a copy of Romania’s situation. For week 44, ECDC reported relatively low influenza activity in the EU/EEA, increasing in several countries, with no regional epidemic onset. The median positivity reported in primary and secondary care was around 5%.
ECDC data aggregate different reporting systems and territories. They cannot automatically disprove or confirm the national situation. Likewise, Romanian data do not show that all European countries are at the same stage. The more modest, accurate connection is this: Romania’s signal of early circulation comes in a European context in which influenza is increasing but does not yet dominate regionally.
For a broader look at the start of the respiratory season, readers can also consult InfoBuz’s analysis of European respiratory indicators and their limits.
What families can reasonably do in the coming weeks
The decision on vaccination should be discussed with a doctor, particularly during pregnancy, in the case of chronic illness or severe allergies, or where there are questions about contraindications. For many eligible people, the practical step is to check the prescription, pharmacy or clinic available to them rather than wait for a formal declaration of an epidemic.
- A vulnerable person or their carer can check early on whether they qualify for reimbursement and what vaccination route is available.
- If one pharmacy does not have the product available, that does not prove that the vaccine is unavailable nationally; availability can vary locally and change over time.
- Ventilating rooms, hand hygiene and avoiding close contact when respiratory symptoms appear remain useful measures, but they do not replace vaccination for those who are eligible.
- A high-risk person who develops a fever, feels very unwell, has difficulty breathing, chest pain, confusion, dehydration or rapidly worsening symptoms should seek medical assessment. In an emergency, call 112.
At the end of October, the Health Ministry had announced doses in storage and an estimated later delivery. This information is useful for the national picture, but cannot confirm what is available in a particular pharmacy on the day it is sought. Local access should be checked directly.
What to monitor, without turning every report into an alarm
In the next bulletins, the course of influenza should be read through several signals: trends in clinical cases, laboratory confirmations and identified virus types, severe cases and hospitalisations, deaths, and actual access to vaccination. A single number can show only part of the picture.
The data available in mid-November show that waiting is no longer entirely neutral for vulnerable people. At the same time, they do not justify claims of a “wave” or an imminent peak. The proportionate message is simpler: arrange protection before pressure on clinics and hospitals increases, and seek medical help without delay if severe symptoms or deterioration develop in a frail person.
Frequently asked questions
Do 68,467 respiratory infections mean Romania has 68,467 flu cases?
No. The total includes several types of respiratory infections, including acute upper respiratory tract infections and pneumonia. In the same week, 273 clinical flu cases were reported separately.
How long does protection take to develop after a flu vaccine?
Health Ministry guidance indicates around two weeks. Vaccination can remain useful during the season, but protection does not begin on the day the vaccine is administered.
Do two confirmed flu deaths mean there is an epidemic?
No. The deaths confirm that influenza can have serious consequences, especially for older people, but they do not by themselves define the intensity of the whole season or amount to a declaration of an epidemic.
Who can receive a reimbursed flu vaccine in Romania?
The CNAS protocol provides full reimbursement for several groups, including children, pregnant women, people over 65 and people with certain chronic illnesses. People aged 45 to under 65 without chronic illnesses receive 50% reimbursement, under the terms of the protocol. A doctor or pharmacist can confirm individual eligibility.
Sources consulted
- AGERPRES — INSP: 68,467 respiratory infection cases reported during 2–8 November
- ECDC — Weekly respiratory virus update, week 44, 2026
- WHO Europe — Get ready for this year’s influenza season: vaccination is key
- Health Ministry — Guide to vaccinating the population against seasonal influenza in pharmacies
- CNAS — Therapeutic protocol for the influenza vaccine










Discuția cititorilor
Ai o opinie sau o întrebare despre acest articol? Spune-ne ce crezi.
Fii primul care deschide discuția.
Te rugăm să păstrezi un limbaj civilizat și să discuți la subiect. Comentariile spam sunt filtrate automat.